Home / news / Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Consensus Alert

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Consensus Alert

collected by :Rechard Bernard

follow the latest news of” market news” from different sites to most famous technicals /Yankee Staff Writer by 2017-01-06 at 18:9

as informed in

Is There Any Upside to Zimmer Biomet Holdings Inc (NYSE:ZBH), Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)?

Is There Any Upside to Zimmer Biomet Holdings Inc (NYSE:ZBH), Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)?*/

– Wall Street sell-side research analysts covering Zimmer Biomet Holdings Inc (NYSE:ZBH) shares have recently provided various price target projections on where the stock might be going.According to them, the stock is expected to reach $133.375 on a consensus level within the next year, according to Zacks.The most bullish estimate sees the stock reaching $155 while the most conservative estimate stand at $111.
.

read more from here

Regeneron Pharmaceuticals, Inc. (REGN) Stake Decreased by Cadian Capital Management LP

Regeneron Pharmaceuticals, Inc. (REGN) Stake Decreased by Cadian Capital Management LP*/

– Cadian Capital Management LP reduced its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) by 50.0% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC).The institutional investor owned 10,000 shares of the biopharmaceutical company’s stock after selling 10,000 shares during the period.Cadian Capital Management LP’s holdings in Regeneron Pharmaceuticals were worth $4,020,000 at the end of the most recent reporting period.
.

read more from here

Regeneron Pharmaceuticals, Inc. (REGN) Stake Decreased by Mitsubishi UFJ Kokusai Asset Management Co. Ltd.

Regeneron Pharmaceuticals, Inc. (REGN) Stake Decreased by Mitsubishi UFJ Kokusai Asset Management Co. Ltd.*/

– Mitsubishi UFJ Kokusai Asset Management Co. Ltd. decreased its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) by 12.4% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC).The institutional investor owned 56,938 shares of the biopharmaceutical company’s stock after selling 8,067 shares during the period.Mitsubishi UFJ Kokusai Asset Management Co. Ltd. owned 0.05% of Regeneron Pharmaceuticals worth $22,890,000 at the end of the most recent quarter.
.

read more from here

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Consensus Alert

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Consensus Alert*/

– Wall Street sell-side analysts have given shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) a near-term target price of $448.This is the consensus number provided by analysts used by Zacks Research.The number includes targets provided by 16 analysts.
.

read more from here

read more
visit us
news

Check Also

United Airlines made headlines after a doctor was violently dragged off a flight picture-12419-310x165

United Airlines made headlines after a doctor was violently dragged off a flight

The incident took place on United Airlines Flight 1737 which was headed from Houston (IAH) …